Want to see CJMB full AI Analyst Report?
CJMB Stock Chart & Stats
$2.10
-$0.07(-2.78%)
At close: 4:00 PM EDT
$2.10
-$0.07(-2.78%)
Day’s Range― - ―
52-Week Range$0.65 - $5.61
Previous CloseN/A
Volume1.77M
Average Volume (3M)10.79K
Market Cap
$12.31M
Enterprise Value$5.82
Total Cash (Recent Filing)$860.27K
Total Debt (Recent Filing)$2.14M
Price to Earnings (P/E)―
Beta-0.35
Next Earnings
Nov 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.00
Shares Outstanding5,752,368
10 Day Avg. Volume12,214
30 Day Avg. Volume10,793
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)2.09
Price to Sales (P/S)0.85
P/FCF Ratio-0.94
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Resilient Gross MarginMaintained gross margins indicate the core service can retain meaningful value per dollar of sales. If revenue stabilizes, this margin profile could support operating recovery, although current overhead remains too high for the business to reach profitability.
Williston Basin Asset ExpansionThe acquisition could broaden Callan JMB’s operating asset base and create a larger platform for future revenue generation. The transaction also introduces experienced sector leadership, though execution, diligence and approval requirements remain important.
Expanded Financing AccessA larger committed equity facility improves access to capital for working capital, acquisitions and business development. This may reduce near-term funding constraints and support strategic execution, although the structure can create substantial shareholder dilution.
Bears Say
Severe Revenue ContractionThe sustained revenue decline signals a major loss of operating scale and market traction. Lower sales reduce the ability to absorb fixed costs, making a return to profitability dependent on rebuilding demand or materially restructuring the cost base.
Persistent Cash BurnNegative operating and free cash flow show that current operations are not self-funding. Continued cash burn could force additional equity issuance, asset sales or external financing, limiting strategic flexibility and increasing dependence on capital markets.
Nasdaq Listing Compliance RiskThe compliance notice creates a structural listing risk that could affect investor access, liquidity and financing flexibility if unresolved. A reverse split or delisting process could also increase governance complexity and impair the company’s capital-raising options.
Callan JMB, Inc. News
CJMB FAQ
What was Callan JMB, Inc.’s price range in the past 12 months?
Callan JMB, Inc. lowest stock price was $0.65 and its highest was $5.61 in the past 12 months.
What is Callan JMB, Inc.’s market cap?
Callan JMB, Inc.’s market cap is $12.31M.
When is Callan JMB, Inc.’s upcoming earnings report date?
Callan JMB, Inc.’s upcoming earnings report date is Nov 13, 2026 which is in 77 days.
How were Callan JMB, Inc.’s earnings last quarter?
Callan JMB, Inc. released its earnings results on Aug 13, 2026. The company reported -$0.218 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Callan JMB, Inc. overvalued?
According to Wall Street analysts Callan JMB, Inc.’s price is currently Overvalued.
Does Callan JMB, Inc. pay dividends?
Callan JMB, Inc. does not currently pay dividends.
What is Callan JMB, Inc.’s EPS estimate?
Callan JMB, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Callan JMB, Inc. have?
Callan JMB, Inc. has 5,752,368 shares outstanding.
What happened to Callan JMB, Inc.’s price movement after its last earnings report?
Callan JMB, Inc. reported an EPS of -$0.218 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.023%.
Which hedge fund is a major shareholder of Callan JMB, Inc.?
Currently, no hedge funds are holding shares in CJMB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Callan JMB, Inc.
Callan JMB Inc., operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life sciences sector. The company's services include comprehensive frozen shipping capabilities essential for a wide range of sensitive biological and medical materials. These critical shipments encompass items such as personalized medicines, cell-based therapies, stem cells, cell lines, vaccines, diagnostic samples, reproductive materials (including semen, eggs, and embryos), cord blood, organs, biopharmaceutical products, infectious substances, and other vital commodities. Additionally, Callan JMB Inc. offers packaging services for other perishable (non-pharmaceutical) client goods, alongside technical support. The company was founded in 2006 and is based in Spring Branch, Texas.
Technical Analysis
Freightos Limited
―
Jayud Global Logistics Limited Class A
―
Armlogi Holding Corp
―
New Century Logistics (BVI) Ltd.
―
Smart Logistics Global Limited
―
Ownership Overview
55.47% Insiders
0.41% Mutual Funds
4.68% Other Institutional Investors
39.32% Public Companies and
Individual Investors